[1]
|
彭珊, 赵钢, 李春艳. 肠易激综合征的发病机制研究进展[J]. 中国医药导报, 2016, 13(6): 54-57.
|
[2]
|
Drossman, D.A. and Hasler, W.L. (2016) Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction. Gastroenterology, 150, 1257-1261. https://doi.org/10.1053/j.gastro.2016.03.035
|
[3]
|
杜海涛, 陈峥, 万军. 肠易激综合征的病理机制研究进展[J]. 解放军医学院学报, 2017, 38(1): 85-88.
|
[4]
|
张子悦, 马书进, 贺新月, 等. 肠易激综合征的发病机制及治疗研究进展[J]. 临床消化病杂志, 2019, 31(1): 60-63.
|
[5]
|
Wouters, M.M., Van Wanrooy, S., Nguyen, A., et al. (2016) Psychological Comorbidity Increases the Risk for Post Infectious IBS Partly by Enhanced Susceptibility to Develop Infectious Gastroenteritis. Gut, 65, 1279-1288.
https://doi.org/10.1136/gutjnl-2015-309460
|
[6]
|
Matricon, J., Meleine, M., Gelot, A., et al. (2012) Review Article: Associations between Immune Activation. Intestinal Permeability and Their Irritable Bowel Syndrome. Alimentary Pharmacology & Therapeutics, 36, 1009-1031.
https://doi.org/10.1111/apt.12080
|
[7]
|
李珊, 方秀才. 肠道炎症在肠易激综合征发病中的作用[J]. 中华消化杂志, 2010, 30(10): 788-790.
|
[8]
|
古巧燕, 张军. 肠易激综合征发病机制研究新进展[J]. 胃肠病学和肝病学杂志, 2017, 26(12): 1420-1423.
|
[9]
|
何佳璨, 周桂荣, 李欣欣, 等. 肠道菌群与肠易激综合征相关研究进展[J]. 中国微生态学杂志, 2020, 32(1): 117-124.
|
[10]
|
池肇春. 肠道菌群生态失衡与肠易激综合征[J]. 胃肠病学, 2015, 20(3): 188-190.
|
[11]
|
潘鑫, 刘茜, 张晓岚. 小肠细菌过度生长在肠易激综合征发病机制中的作用[J]. 胃肠病学, 2020, 25(9): 552-555.
|
[12]
|
王帅, 左丽娟, 高扬, 等. 小肠细菌过度生长的治疗研究进展[J]. 临床消化病杂志, 2021, 33(4): 303-306.
|
[13]
|
Shukla, R., Ghoshal, U., Dhole, T.N., et al. (2015) Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis. Digestive Diseases and Sciences, 60, 2953-2962. https://doi.org/10.1007/s10620-015-3607-y
|
[14]
|
连佳, 孙立霞, 尹伟利. 肠道微生态失衡在肠易激综合征发病机制中的研究进展[J]. 山西医药杂志, 2021, 50(5): 739-742.
|
[15]
|
岑泳欣, 王立生. 利福昔明治疗肠易激综合征的研究进展[J]. 医学综述, 2017, 23(4): 747-751.
|
[16]
|
吴淑娟, 潘建春. 肠易激综合征发病机制研究进展[J]. 温州医科大学学报, 2015(5): 387-391.
|
[17]
|
Holtmann, G.J., Ford, A.C. and Talley, N.J. (2016) Pathophysiology of Irritable Bowel Syndrome. The Lancet Gastroenterology and Hepatology, 1, 133-146. https://doi.org/10.1016/S2468-1253(16)30023-1
|
[18]
|
Pellissier, S. and Bonaz, B. (2017) The Place of Stress and Emotions in the Irritable Bowel Syndrome. Vitamins and Hormones, 103, 327-354. https://doi.org/10.1016/bs.vh.2016.09.005
|
[19]
|
Distrutti, E., Monaldi, L., Ricci, P. and Fiorucci, S. (2016) Gut Microbiota Role in Irritable Bowel Syndrome: New Therapeutic Strategies. World Journal of Gastroenterology, 22, 2219-2241. https://doi.org/10.3748/wjg.v22.i7.2219
|
[20]
|
Mearin, F., Ciriza, C., Minguez, M., et al. (2016) Clinical Practice Guideline: Irritable Bowel Syndrome with Constipation and Functional Constipation in the Adult. Revista espanola de Enfermedades Digestivas, 108, 332-363.
https://doi.org/10.17235/reed.2016.4389/2016
|
[21]
|
Gonlachanvit, S. (2010) Are Rice and Spicy Diet Good for Functional Gastrointestinal Disorder. Journal of Neurogastroenterology and Motility, 16, 131-138. https://doi.org/10.5056/jnm.2010.16.2.131
|
[22]
|
郑洁, 党彤. 生活方式及饮食习惯对肠易激综合征的影响[J]. 中国临床新医学, 2016, 9(4): 301-304.
|
[23]
|
Altobelli, E., Del Negro, V., Angeletti, P.M. and Latella, G. (2017) Low-FODMAP Diet Improves Irritable Bowel Syndrome Symptoms: A Meta-Analysis. Nutrients, 9, 940. https://doi.org/10.3390/nu9090940
|
[24]
|
李小雪, 史立军. 食物不耐受在IBS发病机制中的作用[J]. 哈尔滨医科大学学报, 2019, 53(5): 517-519.
|
[25]
|
Cuomo, R., Andreozzi, P., Zito, F.P., Passananti, V., De Carlo, G. and Sarnelli, G. (2014) Irritable Bowel Syndrome and Food Interaction. World Journal of Gastroenterology, 20, 8837-8845.
|
[26]
|
Ladabaum, U., Boyd, E., Zhao, W.K., et al. (2012) Diagnosis Comorbidities, and Management of Irritable Bowel Syndrome in Patients in a Large Health Maintenance Organization. Clinical Gastroenterology and Hepatology, 10, 37-45.
https://doi.org/10.1016/j.cgh.2011.08.015
|
[27]
|
马丹, 李强, 刘敏, 等. 肠易激综合征治疗进展[J]. 胃肠病学和肝病学杂志, 2019, 28(11): 1287-1291.
|
[28]
|
杨洁, 任茜, 郭庆红, 等. 功能性胃肠病发病机制与治疗方法的研究进展[J]. 山东医药, 2019, 59(2): 87-90.
https://doi.org/10.3969/j.issn.1002-266X.2019.02.026
|
[29]
|
Cozma-Petrut, A., Loghin, F., Miere, D., et al. (2017) Diet in Irritable Bowel Syndrome: What to Recommend Not What to Forbid to Patients! World Journal of Gastroenterology, 23, 3771-3783.
https://doi.org/10.3748/wjg.v23.i21.3771
|
[30]
|
Camilleri, M. (2018) Management Options for Irritable Bowel Syndrome. Mayo Clinic Proceedings, 93, 1858-1872.
https://doi.org/10.1016/j.mayocp.2018.04.032
|
[31]
|
张旭, 汤海涛. 肠易激综合征的药物治疗[J]. 临床消化病杂志, 2015, 27(1): 52-56.
|
[32]
|
Zannini, E. and Arendt, E.K. (2018) Low FODMAPs and Gluten-Free Foods for Irritable Bowel Syndrome Treatment: Lights and Shadows. Food Research International, 110, 33-41. https://doi.org/10.1016/j.foodres.2017.04.001
|
[33]
|
邵亮, 吴华清. 肠易激综合征的治疗进展[J]. 中国医药指南, 2016, 14(1): 31-32.
|
[34]
|
Rajilictojanovic, M., et al. (2008) Clinical Trial: Multispecies Probiotic Supplementation Alleviates the Symptoms of Irritable Bowel Syndrome and Stabilizes Intestinal Microbiota. Alimentary Pharmacology & Therapeutics, 27, 48-57.
|
[35]
|
Herndon, C.C., Wang, Y.P. and Lu, C.L. (2020) Targeting the Gut Microbiota for the Treatment of Irritable Bowel Syndrome. The Kaohsiung Journal of Medical Sciences, 36, 160-170. https://doi.org/10.1002/kjm2.12154
|
[36]
|
Radovanovic-Dinic, B., Tesic-Rajkovic, S., Grgov, S., Petrovic, G. and Zivkovic, V. (2018) Irritable Bowel Syndrome—From Etiopathogenesis to Therapy. Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 162, 1-9. https://doi.org/10.5507/bp.2017.057
|
[37]
|
El-Salhy, M., Hatlebakk, J.G., Gilja, O.H., Bråthen Kristoffersen, A. and Hausken, T. (2020) Efficacy of Faecal Microbiota Transplantation for Patients with Irritable Bowel Syndrome in a Randomised, Double-Blind, Placebo-Controlled Study. Gut, 69, 859-867. https://doi.org/10.1136/gutjnl-2019-319630
|
[38]
|
朱坤, 唐燕锋, 张正怡, 等. 肠易激综合征认知行为干预疗法研 究进展[J]. 山东医药, 2018, 58(38): 90-93.
https://doi.org/10.3969/j.issn.1002-266X.2018.38.028
|
[39]
|
胡晶晶, 刘劲松. 神经递质调节剂在肠易激综合征治疗中的应用[J]. 医学新知, 2021, 31(6): 460-465.
|
[40]
|
Ford, A.C., Sperber, A.D., Corsetti, M. and Camilleri, M. (2020) Irritable Bowel Syndrome. The Lancet, 396, 1675-1688.
|
[41]
|
李国军. 马来酸曲美布汀联合帕罗西汀治疗肠易激综合征的临床研究[J]. 中国处方药, 2014, 12(8): 48-49.
|
[42]
|
Ghadir, M.R., Habibinejad, H., Heidari, A., et al. (2011) Doxepinis More Effective than or Triptyline and Placebo for the Treatment of Diarhea—Predominant Irritable Bowel Syndrome: A Randomized Triple—Blind Placebo—Controlled Trial. Tehran University Medical Journal, 69, 352-358.
|
[43]
|
Layer, P. and Andresen, V. (2010) Review Article: Rifaximin, a Minimally Absorbed Oral Antibacterial, for the Treatment of Travellers, Diarrhoea. Alimentary Pharmacology & Therapeutics, 31, 1155-1164.
https://doi.org/10.1111/j.1365-2036.2010.04296.x
|
[44]
|
罗哲, 李超, 王晓辉, 等. 利福昔明联合枯草杆菌二联活菌肠溶胶囊对伴有小肠细菌过度生长的腹泻型IBS的疗效分析[J]. 解放军医学杂志, 2021, 46(10): 997-1002.
|
[45]
|
Quigley, E.M. (2014) Small Intestinal Bacterial Overgrowth: What It Is and What It Is Not. Current Opinion in Gastroenterology, 30, 141-146. https://doi.org/10.1097/MOG.0000000000000040
|
[46]
|
杨倩, 王小天, 杜姚, 等. 便秘型肠易激综合征药物治疗研究进展[J]. 辽宁中医药大学学报, 2015, 17(6): 5-8.
|
[47]
|
Rey, E., Mearin, F., Alcedo, J., et al. (2017) Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report. Advances in Therapy, 34, 587-598.
https://doi.org/10.1007/s12325-016-0473-8
|